Kim HJ - Search Results

1

Analysis of the core gene of hepatitis B virus in Korean patients.

Kim HJ, Lee DH, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC. Kim HJ, et al. Liver Int. 2007 Jun;27(5):633-8. doi: 10.1111/j.1478-3231.2007.01481.x. Liver Int. 2007. PMID: 17498248

2

Precore and core promoter mutations of hepatitis B virus and hepatitis B e antigen-negative chronic hepatitis B in Korea.

Yoo BC, Park JW, Kim HJ, Lee DH, Cha YJ, Park SM. Yoo BC, et al. Among authors: kim hj. J Hepatol. 2003 Jan;38(1):98-103. doi: 10.1016/s0168-8278(02)00349-5. J Hepatol. 2003. PMID: 12480566

3

[The prevalence and clinical significance of precore and core promoter mutations in Korean patients with chronic hepatitis B virus infection].

Kim HJ, Yoo BC. Kim HJ, et al. Taehan Kan Hakhoe Chi. 2002 Jun;8(2):149-56. Taehan Kan Hakhoe Chi. 2002. PMID: 12499800 Korean.

4

[Relationship between core gene mutations of hepatitis B virus and response to alpha interferon therapy in chronic hepatitis B].

Yoo BC, Kim HJ, Do JH, Park SM. Yoo BC, et al. Among authors: kim hj. Taehan Kan Hakhoe Chi. 2002 Dec;8(4):381-8. Taehan Kan Hakhoe Chi. 2002. PMID: 12506242 Korean.

5

Rescue monotherapy in lamivudine-resistant hepatitis B e antigen-positive chronic hepatitis B: adefovir versus entecavir.

Lee JM, Kim HJ, Park JY, Lee CK, Kim DY, Kim JK, Lee HW, Paik YH, Lee KS, Han KH, Chon CY, Hong SP, Nguyen T, Ahn SH. Lee JM, et al. Among authors: kim jk, kim hj, kim dy. Antivir Ther. 2009;14(5):705-12. Antivir Ther. 2009. PMID: 19704174 Clinical Trial.

6

[Efficacy of 48-week clevudine therapy for chronic hepatitis B].

Kim MH, Kim KA, Lee JS, Lee HW, Kim HJ, Yun SG, Kim NH, Bae WK, Moon YS. Kim MH, et al. Among authors: kim hj, kim ka, kim nh. Korean J Hepatol. 2009 Sep;15(3):331-7. doi: 10.3350/kjhep.2009.15.3.331. Korean J Hepatol. 2009. PMID: 19783882 Korean.

7

Revision and update on clinical practice guideline for liver cirrhosis.

Suk KT, Baik SK, Yoon JH, Cheong JY, Paik YH, Lee CH, Kim YS, Lee JW, Kim DJ, Cho SW, Hwang SG, Sohn JH, Kim MY, Kim YB, Kim JG, Cho YK, Choi MS, Kim HJ, Lee HW, Kim SU, Kim JK, Choi JY, Jun DW, Tak WY, Lee BS, Jang BK, Chung WJ, Kim HS, Jang JY, Jeong SW, Kim SG, Kwon OS, Jung YK, Choe WH, Lee JS, Kim IH, Shim JJ, Cheon GJ, Bae SH, Seo YS, Choi DH, Jang SJ; Korean Association for the Study of the Liver. Suk KT, et al. Among authors: kim ih, kim jk, kim hj, kim su, kim sg, kim dj, kim yb, kim ys, kim hs, kim my, kim jg. Korean J Hepatol. 2012 Mar;18(1):1-21. doi: 10.3350/kjhep.2012.18.1.1. Epub 2012 Mar 22. Korean J Hepatol. 2012. PMID: 22511898 Free PMC article. No abstract available.

8

Simultaneous emergence of entecavir resistance mutations in a nucleoside-naive chronic hepatitis B patient.

Lee HW, Kim HJ, Hong SP, Cha BK, Chang HY, Choi CH, Do JH, Kim JG, Chang SK. Lee HW, et al. Among authors: kim hj, kim jg. Intervirology. 2012;55(5):380-4. doi: 10.1159/000336561. Epub 2012 Apr 24. Intervirology. 2012. PMID: 22538265

9

Durability of viral response after off-treatment in HBeAg positive chronic hepatitis B.

Song MJ, Song DS, Kim HY, Yoo SH, Bae SH, Choi JY, Yoon SK, Paik YH, Lee JS, Lee HW, Kim HJ. Song MJ, et al. Among authors: kim hy, kim hj. World J Gastroenterol. 2012 Nov 21;18(43):6277-83. doi: 10.3748/wjg.v18.i43.6277. World J Gastroenterol. 2012. PMID: 23180949 Free PMC article.

10

Viral evolutionary changes during tenofovir treatment in a chronic hepatitis B patient with sequential nucleos(t)ide therapy.

Lee HW, Chang HY, Yang SY, Kim HJ. Lee HW, et al. Among authors: kim hj. J Clin Virol. 2014 Jul;60(3):313-6. doi: 10.1016/j.jcv.2014.03.018. Epub 2014 Apr 12. J Clin Virol. 2014. PMID: 24836314

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

20,936 results

Search Page